1M
6M
1Y
3Y
5Y
All
| NAV: 13 Dec 2024 | ₹41.80 |
| Min. SIP amount | ₹99 |
| Rating | 3 |
| Fund size | ₹2,793.61Cr |
Return calculator
Monthly SIP
One-Time
₹5,000 per month
Over the past
Total investment of ₹0
Would have become ₹ (%)
Returns and rankings
Category: Equity Sectoral
Annualised returns
Absolute returns
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund returns | 40.8% | 20.0% | 30.4% | 24.8% |
| Category average | 43.0% | 19.8% | 27.0% | NA |
| Rank with in category | 7 | 6 | 2 | NA |
Understand terms
Holdings (31)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 12.00% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 8.05% |
Cipla Ltd. | Healthcare | Equity | 6.80% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 6.20% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 6.05% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.51% |
Lupin Ltd. | Healthcare | Equity | 5.30% |
Divi's Laboratories Ltd. | Healthcare | Equity | 4.96% |
Suven Pharmaceuticals Ltd. | Healthcare | Equity | 4.22% |
Krishna Institute of Medical Sciences Ltd | Healthcare | Equity | 3.95% |
Gland Pharma Ltd. | Healthcare | Equity | 3.95% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 3.50% |
Syngene International Ltd. | Healthcare | Equity | 3.18% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 3.05% |
Mankind Pharma Ltd. | Healthcare | Equity | 3.05% |
Strides Pharma Science Ltd. | Healthcare | Equity | 2.58% |
Fortis Healthcare Ltd. | Healthcare | Equity | 2.55% |
Wockhardt Ltd. | Healthcare | Equity | 2.11% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 2.07% |
Ipca Laboratories Ltd. | Healthcare | Equity | 1.89% |
Alkem Laboratories Ltd. | Healthcare | Equity | 1.88% |
Emcure Pharmaceuticals Ltd. | Healthcare | Equity | 1.03% |
Dr. Lal Pathlabs Ltd. | Healthcare | Equity | 0.88% |
Biocon Ltd. | Healthcare | Equity | 0.87% |
Neogen Chemicals Ltd. | Chemicals | Equity | 0.81% |
Sanofi India Ltd. | Healthcare | Equity | 0.66% |
SRF Ltd. | Diversified | Equity | 0.56% |
Ajanta Pharma Ltd. | Healthcare | Equity | 0.51% |
Sanofi Consumer Healthcare India Ltd. | Healthcare | Equity | 0.48% |
Natco Pharma Ltd. | Healthcare | Equity | 0.44% |
Mirae Asset Liquid Fund Direct- Growth | NA | Mutual Fund | 0.01% |
See All
Pros and cons
Category: Equity Sectoral
Pros
Lower expense ratio: 0.47%
3Y and 5Y annualised returns higher than category average
Cons
1Y annualised returns lower than category average by 0.06%
Expense ratio, exit load and tax
Expense ratio: 0.47%
Inclusive of GST
Exit load
Exit load of 1% if redeemed within 1 year.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Understand terms
Check past data
Minimum investment amounts
| Min. for 1st investment | ₹5,000 |
| Min. for 2nd investment onwards | ₹1,000 |
| Min. for SIP | ₹99 |
Fund management
Vrijesh KaseraJun 2018 - PresentView details
Vrijesh Kasera
Jun 2018 - Present
View details
Education
Mr. Kasera is a MBA (Finance), CFA (ICFAI).
Experience
Prior to joining Mirae Asset Mutual Fund, he was associated with Axis Capital Ltd. as an Equity Research Analyst. He has also been associated with Edelweiss Broking Ltd.
Also manages these schemes
Fund house & investment objective
Fund house contact details
Address
Unit No.606 - 6th Floor,Windsor Building - Off. CST Road,Kalina, Santacruz (East), Mumbai 400098
Phone
022-67800301 / 1800-2090-777
Launch Date
30 Nov 2007
E-mail
NAWebsite
www.miraeassetmf.co.in
Mirae Asset Mutual Fund
Asset Management Company
Custodian
Deutsche Bank
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,
Email
[email protected]Website
www.karvymfs.comCompare funds
Mirae Asset Healthcare Fund Direct Growth
VS
Add mutual fund to compare
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES: S&P BSE SENSEX | S&P BSE 100 | NIFTY 100 | NIFTY 50 | NIFTY MIDCAP 100 | NIFTY BANK | NIFTY NEXT 50
POPULAR MUTUAL FUNDS: QUANT SMALL CAP FUND | ICICI PRUDENTIAL COMMODITIES FUND | NIPPON INDIA SMALL CAP FUND | PARAG PARIKH FLEXI CAP FUND | GROWW NIFTY TOTAL MARKET INDEX FUND | SBI SMALL MIDCAP FUND | TATA DIGITAL INDIA FUND | AXIS SMALL CAP FUND | ICICI PRUDENTIAL TECHNOLOGY FUND | HDFC INDEX FUND SENSEX PLAN | HDFC SMALL CAP FUND | AXIS EQUITY FUND | CANARA ROBECO SMALL CAP FUND | TATA SMALL CAP FUND | UTI NIFTY FUND
MUTUAL FUNDS COMPANIES: GROWWMF | SBI | AXIS | HDFC | UTI | NIPPON INDIA | ICICI PRUDENTIAL | TATA | KOTAK | DSP | CANARA ROBECO | SUNDARAM | MIRAE ASSET | IDFC | FRANKLIN TEMPLETON | PPFAS | MOTILAL OSWAL | INVESCO | EDELWEISS | ADITYA BIRLA SUN LIFE | LIC | HSBC | NAVI | QUANTUM | UNION | ITI | MAHINDRA MANULIFE | 360 ONE | BOI | TAURUS | JM FINANCIAL | PGIM | SHRIRAM | BARODA BNP PARIBAS | QUANT | WHITEOAK CAPITAL | TRUST | SAMCO | NJ